FTO and obesity due to melanocortin 4 receptor deficiency: - Anti-obesity (↓body weight, fat mass, visceral fat; ↓serum TC, TG, glucose; ↑basal metabolic rate) in obese humans (214 participants, 1,000 mg/day, 6 months), the presence of polymorphisms FTO might hamper these beneficial effects.